Stevanato Group S.P.A. (STVN) closed at $13.91 on November 11, 2026, up 2.8% from the previous close, on volume of 1,014,828 shares (30-day average 829,874).
Data as of November 11, 2026.
11-Nov-2026
TipRanks (Mon, 9-Nov 4:45 PM ET)
STVN Investors Have Opportunity to Join Stevanato Group S.p.A. Fraud Investigation with SBS Law
Business Wire (Sat, 7-Nov 6:27 PM ET)
STVN INVESTOR ALERT: Investigation of Stevanato Group S.p.A. Announced by Holzer & Holzer, LLC
Globe Newswire (Wed, 4-Nov 5:05 PM ET)
Business Wire (Wed, 4-Nov 1:20 PM ET)
Business Wire (Wed, 4-Nov 12:20 PM ET)
Business Wire (Wed, 4-Nov 12:12 PM ET)
Stevanato Group (STVN) Shareholder Investigation Following Stock Decline - Kehoe Law Firm, P.C.
Globe Newswire (Wed, 4-Nov 8:38 AM ET)
PRNewswire (Tue, 3-Nov 5:38 PM ET)
Stevanato Group Delivers 8% Revenue Growth for the Third Quarter of Fiscal 2026
Business Wire (Tue, 3-Nov 6:30 AM ET)
Stevanato Group and Aptar Pharma Collaborate to Help Accelerate Pre-Filled Syringe System Selection
Business Wire (Tue, 27-Oct 7:00 AM ET)
Stevanato Group is a provider of glass and polymer drug containment, drug delivery, and diagnostic solutions to the pharmaceutical and life sciences industries. The company operates through two segments: a Biopharmaceutical and Diagnostic Solutions segment, which offers an integrated, end-to-end portfolio of products, processes, and services spanning the full drug lifecycle; and an Engineering segment, which designs, develops, and manufactures advanced machinery for pharmaceutical manufacturing, covering visual inspection, assembly and packaging, glass converting, and serialization. Stevanato's revenue is geographically diversified, with approximately 60% of sales generated in Europe, the Middle East, and Africa, 30% in North America, 8% in Asia-Pacific, and 2% in South America.
Stevanato Group S.P.A. trades on the NYSE stock market under the symbol STVN.
As of November 11, 2026, STVN stock price climbed to $13.91 with 1,014,828 million shares trading.
STVN has a beta of 1.73, meaning it tends to be more sensitive to market movements. STVN has a correlation of 0.18 to the broad based SPY ETF.
STVN has a market cap of $3.79 billion. This is considered a Mid Cap stock.
Last quarter Stevanato Group S.P.A. reported $375 million in Revenue and $.18 earnings per share. This beat revenue expectation by $11 million and exceeded earnings estimates by $.01.
In the last 3 years, STVN traded as high as $34.73 and as low as $12.05.
The top ETF exchange traded funds that STVN belongs to (by Net Assets): IBB, NBSM, KOMP, SMLV, SCAP.
STVN has underperformed the market in the last year with a price return of -42.2% while the SPY ETF gained +12.4%. STVN has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -33.9% and -28.4%, respectively, while the SPY returned -1.1% and -1.6%, respectively.
STVN support price is $13.14 and resistance is $13.92 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that STVN shares will trade within this expected range on the day.
